Timothy Hirst
Family Medicine · Sebring, OHNPI 1215937750
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 11.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,321 and has fallen 52.1% since, to $633 in 2022.
Across 201 payments — averaging $14.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$338
- Boehringer Ingelheim$297
- Pfizer$274
- Vanda Pharmaceuticals Inc.$259
- Sanofi-aventis U.S. LLC$231
- AstraZeneca$208
- plus $1K from 16 others
What the payments were for
- Food & beverage$2,894100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $338 |
| Boehringer Ingelheim | 25 | $297 |
| Pfizer | 19 | $274 |
| Vanda Pharmaceuticals Inc. | 15 | $259 |
| Sanofi-aventis U.S. LLC | 16 | $231 |
| AstraZeneca | 11 | $208 |
| Novo Nordisk | 14 | $200 |
| Sunovion Pharmaceuticals Inc. | 12 | $164 |
| Lilly USA, LLC | 11 | $157 |
| Biohaven Pharmaceuticals, Inc. | 11 | $132 |
| GSK | 9 | $128 |
| Teva Pharmaceuticals USA, Inc. | 7 | $123 |
| Amarin Pharma, Inc. | 6 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $73 |
| Amgen | 4 | $53 |
| Mannkind Corporation | 3 | $44 |
| Almatica Pharma LLC | 3 | $43 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Merck | 2 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Athena Bioscience, LLC | 1 | $11 |
How this compares
$2,894 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 22 | $501 |
| Diazepam | 12 | $138 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Sebring
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
- David NeidhardtLima$248K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.